Bioequivalence and Bioavailability Forum

What would be the study design for gliclazide 80mg tablet for Europe, WHO & HKG prasad.v 2021-07-29 10:33
- No acceptance criteria widening for AUC in Europe vixen 2021-07-30 18:44

statistical approaches for dose-finding PK studies Sridhar.E 2021-07-13 11:04
- statistical approaches for dose-finding PK studies msmnainar 2021-07-17 19:04

Bracketing approach for multiple strenght product EMA jag009 2021-07-06 19:19
- Bracketing approach for multiple strenght product EMA dshah 2021-07-17 11:44

Ethnicity of Indian population Vishal S 2021-06-22 07:25
- Ethnicity of Indian population drgunasakaran1 2021-06-24 06:06
  - Ethnicity of Indian population VijithRoy 2021-06-30 06:43
- Ethnicity of Indian population Achievwin 2021-07-06 16:21

End study requirements for Brazil submission khageswara Rao 2021-07-01 08:43
- End study requirements for Brazil submission drgunasakaran1 2021-07-05 10:15

Nitrofurantoin BE study pjs 2015-07-30 08:55
- Nitrofurantoin BE study drgunasakaran1 2015-08-02 14:56
  - Nitrofurantoin BE study pjs 2015-08-03 10:06
- Nitrofurantoin BE study pjs 2015-08-07 04:10
  - Nitrofurantoin BE study pjs 2015-08-27 15:36
    - Nitrofurantoin BE study Dr_Dan 2015-08-28 09:15
      - Nitrofurantoin BE study pjs 2015-08-28 10:37
        
        Nitrofurantoin BE study Dr_Dan 2015-08-31 18:19
        
        Nitrofurantoin BE study AB661 2021-06-15 09:38
        
        Nitrofurantoin BE study Relaxation 2021-06-15 12:10
        
        Nitrofurantoin BE study AB661 2021-06-16 08:13
        
        Nitrofurantoin BE study Relaxation 2021-06-16 12:59

Number of sets selection in In-Vitro Kinetic and Equilibrium Binding study Sivakrishna 2021-06-10 08:12

Guidelines Rams69 2021-06-04 03:46
- Guidelines drgunasakaran1 2021-06-07 13:30
  - Guidelines Rams69 2021-06-09 04:43

Registration with CTRI surajpatel 2021-06-02 07:30
- Registration with CTRI drgunasakaran1 2021-06-02 11:39

AUCrefTmax raghup 2021-05-28 12:44
- AUCrefTmax (Health Canada) Helmut 2021-05-28 12:58
  - AUCrefTmax (Health Canada) raghup 2021-05-28 13:16
    - AUCrefTmax (Health Canada) Helmut 2021-05-28 13:23
    - AUCrefTmax (Health Canada) dshah 2021-05-31 10:15

Regulatory Submission in Europe in Absence of Reference product Abhay Patil 2021-03-23 08:58
- Regulatory Submission in Europe in Absence of Reference product dshah 2021-03-23 09:51
  - Regulatory Submission in Europe in Absence of Reference product Abhay Patil 2021-03-23 10:00
    - Regulatory Submission in Europe in Absence of Reference product drgunasakaran1 2021-05-20 07:20

Cataplasms and study design Pharma_88 2021-04-13 06:31
- Cataplasms and study design drgunasakaran1 2021-05-13 06:43

Doubts regarding IS variation, ISR failure & SEL/SPE Acceptance criteria Rams69 2021-05-12 06:57
- Doubts regarding IS variation, ISR failure & SEL/SPE Acceptance criteria ElMaestro 2021-05-12 09:10
  - Why, oh why? Helmut 2021-05-12 10:46
  - Doubts regarding IS variation, ISR failure & SEL/SPE Acceptance criteria Rams69 2021-05-13 04:08
- Doubts regarding IS variation, ISR failure & SEL/SPE Acceptance criteria Ohlbe 2021-05-12 10:51
  - Doubts regarding IS variation, ISR failure & SEL/SPE Acceptance criteria Rams69 2021-05-13 04:09

ICH E6, r3 ElMaestro 2021-04-27 07:45
- CTTI web conferences Ohlbe 2021-04-27 16:59

Retention samples vinodvasala 2021-04-13 13:27
- Retention samples dshah 2021-04-13 19:07

Admin contact
21,596 posts in 4,516 threads, 1,532 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time: Monday 08:19 CEST (Europe/Vienna)

Imagine if every Thursday your shoes exploded
if you tied them the usual way.
This happens to us all the time with computers,
and nobody thinks of complaining. Jef Raskin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz